Common viral infections may accelerate the onset and progression of amyotrophic lateral sclerosis (ALS), according to new research from McMaster University. The findings suggest that the immune response triggered by infections, rather than direct infection of nerve cells, could contribute to faster disease progression.
Researchers studied animal models of ALS following infection with either influenza A virus or SARS-CoV-2, the virus responsible for COVID-19. Compared with uninfected animals, those exposed to either virus experienced a more rapid decline in motor function.
The researchers investigated the mechanisms underlying this association and found that respiratory viral infections caused persistent changes in the nervous system. Although neither influenza A nor SARS-CoV-2 needs to infect neurons to produce these effects, both infections triggered an inflammatory response in immune cells within the nervous system.
This process, known as gliosis, remained elevated in the spinal cord after the infections had been cleared. Gliosis is already recognised as an important feature of ALS, and the researchers suggest that infection-related inflammation could amplify this process and contribute to faster disease progression.
The study also found evidence that interventions targeting the infection or inflammatory response could influence disease progression in the animal models. Treatment with antiviral medicines and suppression of gliosis using anti-inflammatory treatment were both associated with a significant reduction in the rate of ALS progression.
| Sign up to the ACNR email newsletter here |
The researchers said the findings provide a possible mechanistic explanation for previous observations linking viral infections with neurodegenerative disease. They also suggest that preventing or limiting infections could potentially have benefits beyond reducing the immediate effects of infection.
However, the findings are based on pre-clinical animal models and do not establish that viral infections accelerate ALS progression in people. Further research will be needed to determine whether the mechanisms identified in these models apply to human disease and whether antiviral or anti-inflammatory strategies could have therapeutic value.
This news item has been summarised using AI and checked by humans before publication.
Sources
McMaster University via Newswise
| Sign up for our online community for neurology specialists |

